Michael Adrian Nazak

Chief Financial Officer, Aridis Pharmaceuticals, Inc.

Companies

AN2 Therapeutics, Inc.Chief Accounting Officer Mar 24, 2022 to Feb 17, 2023¹
Aridis Pharmaceuticals, Inc.Chief financial officer Jan 13, 2020 to Feb 22, 2021²

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAN2 Therapeutics, Inc., Chief Accounting Officer
2
SEC EDGARAridis Pharmaceuticals, Inc., Chief financial officer